Recent research focusing on Semaglutide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may amplify the drug's ability to regulate blood sugar, potentially offering greater outcomes for individuals with insulin resistance. Further study is underway to fully understand the long